ABRF 2022: Targeted UPLC-MS/MS Lipidomics for Biomarker Research of Prostate Cancer (PCa) and Therapy Responses in Human Serum

Posters | 2022 | WatersInstrumentation
LC/MS, LC/MS/MS, LC/QQQ
Industries
Clinical Research, Lipidomics
Manufacturer
Waters
Downloadable PDF for viewing
 

Similar PDF

Application of LipidQuan to the Study of Prostate Cancer and the Response to Various Treatment Therapies
HIGH THROUGHPUT LC/MS PLATFORM FOR LARGE SCALE SCREENING OF BIOACTIVE LIPIDS IN HUMAN PLASMA/SERUM
LipidQuan: A Rapid and Comprehensive Targeted Approach Investigating the Lipidome of Bladder Cancer Subjects
LipidQuan for Comprehensive and High-Throughput HILIC-based LC-MS/MS Targeted Lipid Quantitation